HAEM5:Volunteer Assignments and Opportunities: Difference between revisions

[unchecked revision][unchecked revision]
No edit summary
No edit summary
Line 1,368: Line 1,368:
|
|
|-
|-
|Follicular dendritic cell sarcoma
|Disease
|Anna Heimes Dillon, MD and Shivani Golem, PhD, FACMG
|
|
|
|
|
|
|
|
|GC
|
|
|
|
|
|
|-
|EBV-positive inflammatory follicular dendritic cell sarcoma
|Disease
|
|
|
|
|
|GC
|
|
|
|-
|Fibroblastic reticular cell tumour
|Disease
|
|
|
|
|
|GC
|
|
|
|-
|Intranodal palisaded myofibroblastoma
|Disease
|
|
|
|
|
|GC
|
|
|
|-
|Littoral cell angioma
|Disease
|
|
|
|
|
|
|GC
|
|
|
|
|
|
|-
|-
|Splenic hamartoma
|Disease
|
|
|
|
Line 1,385: Line 1,435:
|
|
|
|
|GC
|
|
|
|-
|Sclerosing angiomatoid nodular transformation (SANT) of spleen
|Disease
|
|
|
|
|
|
|
|
|GC
|
|
|
|
Line 1,418: Line 1,478:
|
|
|-
|-
|Follicular dendritic cell sarcoma||Disease||Anna Heimes Dillon, MD and Shivani Golem, PhD, FACMG|| || || || ||SP||
| || || || || || || || ||
| ||
| ||
|-
|-
|EBV-positive inflammatory follicular dendritic cell sarcoma||Disease|| || || || || ||SP||
| || || || || || || || ||
| ||
| ||
|-
|-
|Fibroblastic reticular cell tumour||Disease|| || || || || ||SP||
| || || || || || || || ||
| ||
| ||
|-
|-
|Intranodal palisaded myofibroblastoma||Disease|| || || || || ||SP||
| || || || || || || || ||
| ||
| ||
|-
|-
|Littoral cell angioma||Disease|| || || || || ||SP||
| || || || || || || || ||
| ||
| ||
|-
|-
|Splenic hamartoma||Disease|| || || || || ||SP||
| || || || || || || || ||
| ||
| ||
|-
|-
|Sclerosing angiomatoid nodular transformation (SANT) of spleen||Disease|| || || || || ||SP||
| || || || || || || || ||
| ||
| ||
|-
|
|
|
|
|
|
|
|
|
|
|
|-
|-
|B-lymphoblastic leukaemia/lymphoma||Disease|| || || || || ||YA||
|B-lymphoblastic leukaemia/lymphoma||Disease|| || || || || ||YA||